We are live on ! Find out more
BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

3 hedge funds and large institutions have $36.2M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more capital invested

Capital invested by funds: $24.9M → $36.2M (+$11.3M)

0% more funds holding

Funds holding: 3 → 3 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BHCM
Brevan Howard Capital Management
Jersey
+$326K

Top Sellers

Rank Fund Capital Flow
1
IUHSA
Itau Unibanco Holding S.A.
Brazil
-$3.05K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$35.5M – – –
BC
2
Birchview Capital
Vermont
$368K – – –
BHCM
3
Brevan Howard Capital Management
Jersey
$326K +$326K +6,523 New
IUHSA
4
Itau Unibanco Holding S.A.
Brazil
– -$3.05K -88 Closed

BHVN Hedge Fund Activity: Q3 2024 in Review

3 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q3 2024, worth a combined $36.2M — up 45% from $24.9M a quarter earlier.

Fund positioning in BHVN was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Brevan Howard Capital Management, opening a new position worth an estimated $326K. The largest seller was Itau Unibanco Holding S.A., exiting entirely with an estimated $3.05K sold.

  • 3 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $36.2M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q3 2024, up 45% quarter-over-quarter.
  • 1 fund opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q3 2024 and 1 closed out, a net change of 0 holders.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q3 2024 was Brevan Howard Capital Management, an estimated $326K added.
  • The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q3 2024 was Itau Unibanco Holding S.A., an estimated $3.05K sold.

Based on aggregated 13F filings for Q3 2024.